Sensera announces deal with Abiomed

Company News

by Kathy Skantzos

Sensera (ASX:SE1), a sensor manufacturer and player in the Internet of Things (IoT) market, has disclosed its supply agreement announced on Monday is with Abiomed, a US-based medical device company.

The multimillion dollar agreement with Sensara’s US subsidiary spans three years as a supplier to Abiomed.

The deal embeds Sensera as a part of the supply chain for Abiomed for its medical device that leads its customer portfolio.

Abiomed has a market cap of US$8 billion and produces a number of medical devices including the world’s smallest heart pump.

Sensera Executive Chairman Matt Morgan said manufacturing for this customer will play a meaningful role in delivering year on year revenue growth for the company.

Shares in Sensera (ASX:SE1) closed 2.78 per cent lower to 35 cents a share.

Kathy Skantzos

Finance News Network
Kathy presents the Market Outlook and ASX company news. She joined FNN in September 2017. She has been in print and online journalism for over 9 years. She also worked in corporate communications.